Middle ear neuroendocrine tumours (MeNETs) are rare epithelial neoplasms with neuroendocrine differentiation that pose significant diagnostic and therapeutic challenges. The clinical presentation of MeNETs is often nonspecific and can mimic other middle ear pathologies, such as chronic otitis media, cholesteatoma, or paraganglioma Common symptoms include conductive hearing loss, otalgia, intermittent or persistent...
✦ The floor
Discussion
Signed responses from readers of the wire.
MeNETs are rare enough that no change in routine audiology practice is indicated; however, audiologists encountering unexplained middle ear masses should maintain awareness of this diagnosis and facilitate prompt ENT referral.
As a rare but clinically significant middle-ear pathology that can mimic more common conditions, greater awareness of MeNETs among audiologists and ENT specialists may reduce diagnostic delay.
- 01Middle ear neuroendocrine tumors (MeNETs) are rare epithelial neoplasms presenting diagnostic and therapeutic challenges.
- 02Review covers current strategies for diagnosis including imaging, biopsy, and immunohistochemistry (lab staining to identify tumor cell types).
- 03Management options and challenges, including surgical approaches, are summarized.
- 04Prognosis is generally favorable but recurrence and metastasis are possible.
- 05Published in Life (MDPI journal).
Middle ear neuroendocrine tumors pose significant diagnostic challenges due to their rarity and histological complexity.
opinionsupported- PMID
- 42652974
- DOI
- 10.3390/life16081286.
- Journal
- Life
- Publication type
- review
- Evidence level
- 5
- Population
- Patients with middle ear neuroendocrine tumors (MeNETs)
- Intervention
- Review of diagnostic and management approaches for MeNETs
Primary outcomes
Diagnostic accuracy and approach; Therapeutic strategies and patient outcomes